Search for: "Biovail"
Darl Moreland Joins Alexza Pharmaceuticals as Vice President, Quality
HSMN NewsFeed,
12 Aug 2010:
Biopharmaceuticals, Personnel
[Alexza Pharmaceuticals]
|
Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
HSMN NewsFeed,
22 Jul 2010:
Biopharmaceuticals, Personnel
[Alexza Pharmaceuticals]
|
Valeant and Biovail Agree to Merge
HSMN NewsFeed,
21 Jun 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Valeant Pharmaceuticals, Biovail]
|
Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder
HSMN NewsFeed,
26 May 2010:
Biopharmaceuticals
[Alexza Pharmaceuticals, Biovail, Staccato, loxapine, schizophrenia]
|
Biovail Acquires AMPAKINE(R) Compounds for Treatment of Respiratory Depression
HSMN NewsFeed,
26 Mar 2010:
Biopharmaceuticals, Acquisitions
[Biovail, Biovail Laboratories, Cortex Pharmaceuticals, AMPAKINE]
|
Cortex Sells Selected AMPAKINE Compounds and Rights to Respiratory Depression Indication to Biovail
HSMN NewsFeed,
26 Mar 2010:
Biopharmaceuticals, Acquisitions
[Cortex Pharmaceuticals, Biovail Laboratories, AMPAKINE]
|
Santarus Announces Completion of Enrollment in U.S. Phase III Clinical Study for Budesonide MMX
HSMN NewsFeed,
25 Mar 2010:
Biopharmaceuticals, Drug Delivery, Gastroenterology
[Santarus, Cosmo Pharmaceuticals, budesonide MMX, ulcerative colitis]
|
Biovail Comments on Proposed Generic Wellbutrin XL(R) Trial
HSMN NewsFeed,
22 Jan 2010:
Biopharmaceuticals, Generics
[Biovail, Wellbutrin, Teva Pharmaceutical, bupropion]
|
ACADIA Pharmaceuticals Announces Results from Phase III Trial of Pimavanserin in Parkinson's Disease Psychosis
HSMN NewsFeed,
1 Sep 2009:
Biopharmaceuticals, Neurology
[ACADIA Pharmaceuticals, Pimavanserin, Parkinson’s disease]
|
Biovail to Acquire Rights to Develop, Commercialize JP-1730/Fipamezole in North America from Santhera
HSMN NewsFeed,
24 Aug 2009:
Biopharmaceuticals, Neurology
[Biovail, Biovail Laboratories, Santhera Pharmaceuticals, fipamezole]
|
Biovail Announces Acquisition of Worldwide Rights to Tetrabenazine
HSMN NewsFeed,
18 May 2009:
Biopharmaceuticals, Neurology, Acquisitions
[Biovail, tetrabenazine, Xenazine, Nitoman]
|
Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporation's Board of Directors
HSMN NewsFeed,
11 May 2009:
Biopharmaceuticals, Personnel
[Biovail]
|
GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million
HSMN NewsFeed,
6 May 2009:
Biopharmaceuticals, Asquisitions
[GlaxoSmithKline, Biovail, Wellbutrin XL]
|
Biovail Announces Acquisition of U.S. Rights to Wellbutrin XL
HSMN NewsFeed,
6 May 2009:
Biopharmaceuticals, Acquisitions
[Biovail, Biovail Laboratories, GlaxoSmithKline, Wellbutrin XL]
|
Biovail Enters into Collaboration and License Agreement with Acadia for Pimavanserin
HSMN NewsFeed,
4 May 2009:
Biopharmaceuticals, Licensing, Neurology
[Biovail, ACADIA Pharmaceuticals, pimavanserin, Parkinson’s disease]
|
TransMolecular Appoints Robert Radie President and Chief Executive Officer
HSMN NewsFeed,
7 Apr 2009:
Biopharmaceuticals, Oncology, Personnel
[TransMolecular]
|
Aplenzin(TM), the Only Single Tablet Once-Daily Treatment for Depression at All Doses, Now Available in the United States
HSMN NewsFeed,
7 Apr 2009:
Biopharmaceuticals
[sanofi-aventis, Aplenzin, bupropion, depressive disorder]
|
Biovail Enters into Commercial Alliance for Aplenzin
HSMN NewsFeed,
22 Dec 2008:
Biopharmaceuticals, Distribution
[Biovail, sanofi-aventis, Aplenzin, bupropion]
|
COSMO ANNOUNCES STRATEGIC COLLABORATION WITH SANTARUS FOR U.S. RIGHTS TO BUDESONIDE MMX® AND RIFAMYCIN SV MMX®
HSMN NewsFeed,
15 Dec 2008:
Biopharmaceuticals, Gastroenterology
[Cosmo Pharmaceuticals, Santarus, Budesonide MMX, Rifamycin SV MMX]
|
Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
HSMN NewsFeed,
11 Dec 2008:
Biopharmaceuticals, Personnel
[Cornerstone Therapeutics]
|
Cambridge Laboratories Announces Launch of XENAZINE(R) (Tetrabenazine) in the US
HSMN NewsFeed,
1 Dec 2008:
Biopharmaceuticals, Neurology
[Cambridge Laboratories, XENAZINE, tetrabenazine, Huntington's disease]
|
Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
HSMN NewsFeed,
29 Oct 2008:
Biopharmaceuticals, Personnel
[Cornerstone Therapeutics]
|
MiddleBrook Pharmaceuticals Announces Changes to Management Team
HSMN NewsFeed,
7 Oct 2008:
Biopharmaceuticals, Personnel
[MiddleBrook Pharmaceuticals]
|
Cambridge Laboratories Announces New Marketing Arrangements for XENAZINE(R) in North America
HSMN NewsFeed,
17 Sep 2008:
Biopharmaceuticals, Neurology
[Cambridge Laboratories, XENAZINE, tetrabenazine, Huntington's disease]
|
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
HSMN NewsFeed,
25 Aug 2008:
Biopharmaceuticals, Regulatory
[Biovail, Ralivia]
|
Biovail Appoints Dr. Neil M. Sussman Vice-President, Neurologic & Psychiatric Development
HSMN NewsFeed,
20 Aug 2008:
Biopharmaceuticals, Personnel
[Biovail]
|
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products
HSMN NewsFeed,
22 Jul 2008:
Biopharmaceuticals, Endocrinology
[Santarus, Depomed, GLUMETZA, metformin, diabetes]
|
EyeGate Pharma Adds Drug Development and Delivery Expert, Praveen Tyle, to Its Board of Directors
HSMN NewsFeed,
9 Jun 2008:
Biopharmaceuticals, Ophthalmology, Drug Delivery, Personnel
[EyeGate Pharma, iontophoresis]
|
Teva Announces Launch of Generic Wellbutrin XL(R) Tablets, 150 mg
HSMN NewsFeed,
30 May 2008:
Biopharmaceuticals, Generics, FDA
[Teva Pharmaceutical, Bupropion, Wellbutrin XL, Biovail, GlaxoSmithKline]
|
XenoPort Appoints Vincent J. Angotti as Chief Commercialization Officer
HSMN NewsFeed,
1 May 2008:
Biopharmaceuticals, Personnel
[XenoPort]
|
Biovail Strengthens Leadership Team
HSMN NewsFeed,
21 Apr 2008:
Biopharmaceuticals, Drug Delivery, Personnel
[Biovail]
|
Bradmer announces new additions to management team
HSMN NewsFeed,
2 Apr 2008:
Biopharmaceuticals, Personnel
[Bradmer Pharmaceuticals]
|
Depomed Doses First Patient in New Phase 3 Clinical Trial of Gabapentin GR in Postherpetic Neuralgia
HSMN NewsFeed,
24 Mar 2008:
Biopharmaceuticals
[Depomed, Gabapentin GR, postherpetic neuralgia, neuropathic pain]
|
Depomed Names Abid Rawn Vice President of Sales and Marketing
HSMN NewsFeed,
20 Feb 2008:
Biopharmaceuticals, Personnel
[Depomed]
|
Biovail Receives Letter Related to 2003 Cardizem(R) LA Launch Activities from U.S. Attorney's Office
HSMN NewsFeed,
1 Feb 2008:
Biopharmaceuticals
[Biovail, Cardizem LA, Cardizem]
|
Biovail Announces Supply Agreement for Commercialization of Extended-Release Tramadol
HSMN NewsFeed,
2 Jan 2008:
Biopharmaceuticals, Distribution
[Biovail, Janssen Pharmaceutica, Johnson & Johnson, tramadol]
|
Depomed Receives FDA Approval for 1000 mg Strength Tablets of Glumetza
HSMN NewsFeed,
2 Jan 2008:
Biopharmaceuticals, FDA, Endocrinology, Drug Delivery
[Depomed, Glumetza, metformin, diabetes]
|
Watson and Biovail Settle Lawsuit Over Cardizem(R) LA
HSMN NewsFeed,
4 Dec 2007:
Biopharmaceuticals, Litigation
[Watson Pharmaceuticals, Biovail Laboratories International SRL, Andrx]
|
Biovail Announces Settlement Agreement Related to Cardizem(R) LA
HSMN NewsFeed,
4 Dec 2007:
Biopharmaceuticals, Generics, Litigation
[Biovail, Biovail Laboratories, Watson Pharmaceuticals, Andrx, Cardizem]
|
Depomed Names Michael Sweeney Vice President of Product Development
HSMN NewsFeed,
3 Dec 2007:
Biopharmaceuticals, Personnel
[Depomed]
|
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
HSMN NewsFeed,
27 Nov 2007:
Biopharmaceuticals, Personnel
[Neuromed Pharmaceuticals]
|
Biovail Enters into Development Agreement
HSMN NewsFeed,
7 Nov 2007:
Biopharmaceuticals
[Biovail, Biovail Laboratories International SRL, Pharma Pass II, BVF-068]
|
Biovail Launches Ralivia(TM) to Canadian Physicians
HSMN NewsFeed,
1 Nov 2007:
Biopharmaceuticals, Drug Delivery
[Biovail, Ralivia, tramadol]
|
Depomed and King Pharmaceuticals Terminate Promotion Agreement for GLUMETZA(TM)
HSMN NewsFeed,
29 Oct 2007:
Biopharmaceuticals, Endocrinology
[Depomed, King Pharmaceuticals, GLUMETZA, metformin, diabetes]
|
Depomed Announces Retirement of Chief Financial Officer John F. Hamilton
HSMN NewsFeed,
11 Oct 2007:
Biopharmaceuticals, Personnel
[Depomed]
|
Depomed and Watson Expand ProQuin(R) XR Promotion Agreement to Include Ob/Gyn Field
HSMN NewsFeed,
25 Sep 2007:
Biopharmaceuticals
[Depomed, Watson Pharmaceuticals, ProQuin XR, ciprofloxacin]
|
Depomed Announces Reduction in Force
HSMN NewsFeed,
17 Sep 2007:
Biopharmaceuticals
[Depomed]
|
Dr. John Fara Retires as Chairman, President and CEO of Depomed; Mr. Carl Pelzel Appointed President and CEO
HSMN NewsFeed,
27 Aug 2007:
Biopharmaceuticals, Personnel
[Depomed]
|
Biovail Responds to Investor Enquiries
HSMN NewsFeed,
23 Jul 2007:
Biopharmaceuticals, Drug Delivery, FDA
[Biovail , BVF-033, bupropion]
|
Biovail Provides Update on BVF-033
HSMN NewsFeed,
20 Jul 2007:
Biopharmaceuticals, Drug Delivery, FDA
[Biovail, BVF-033, bupropion]
|
Depomed Announces Results of Phase 3 Clinical Trial for Gabapentin GR(TM) In Postherpetic Neuralgia
HSMN NewsFeed,
10 Jul 2007:
Biopharmaceuticals
[Depomed, Gabapentin GR, postherpetic neuralgia, neuropathic pain]
|
Depomed Reacquires the Rights to ProQuin(R) XR
HSMN NewsFeed,
5 Jul 2007:
Biopharmaceuticals, Acquisitions, Licensing
[Depomed, Esprit Pharma, ProQuin XR, ProQuin, ciprofloxacin]
|
Auriga Laboratories Appoints Leonhard Dreimann and Thomas Heck to its Board of Directors
HSMN NewsFeed,
26 Jun 2007:
Biopharmaceuticals, Personnel
[Auriga Laboratories]
|
Biovail Chairman Eugene Melnyk Announces Retirement
HSMN NewsFeed,
16 May 2007:
Biopharmaceuticals, Personnel
[Biovail]
|
NicOx recruits Sanjiv Sharma as Vice President Commercial Affairs in the United States
HSMN NewsFeed,
30 Apr 2007:
Biopharmaceuticals, Personnel
[NICOX]
|
SCOLR Pharma Announces Positive Ibuprofen Study Results and Status of Commercialization Program
HSMN NewsFeed,
17 Apr 2007:
Biopharmaceuticals
[SCOLR Pharma, ibuprofen]
|
Depomed Files Prior Approval Supplement for 1000 mg Strength Tablets of Glumetza
HSMN NewsFeed,
2 Apr 2007:
Biopharmaceuticals, Endocrinology
[Depomed, Glumetza, metformin hydrochloride, diabetes]
|
IMPAX Settles Patent Litigation Related to Generic Wellbutrin(R) XL
HSMN NewsFeed,
5 Mar 2007:
Biopharmaceuticals, Generics, Litigation
[IMPAX Laboratories, Biovail, Wellbutrin XL]
|
Teva Announces Agreement with Biovail and Anchen Regarding Generic Wellbutrin XL
HSMN NewsFeed,
5 Mar 2007:
Biopharmaceuticals, Generics, Litigation
[Teva Pharmaceutical, Biovail, Wellbutrin XL]
|
Biovail Announces Comprehensive Settlement Related to Wellbutrin XL(R)
HSMN NewsFeed,
5 Mar 2007:
Biopharmaceuticals, Generics, Litigation
[Biovail, Wellbutrin XL]
|
Depomed and Biovail Sign License Agreement for AcuForm(TM) Drug Delivery Technology
HSMN NewsFeed,
12 Feb 2007:
Biopharmaceuticals, Drug Delivery, Licensing
[Depomed, Biovail, AcuForm]
|
Wellbutrin XR(R) Receives First European Approval
HSMN NewsFeed,
16 Jan 2007:
Biopharmaceuticals, Regulatory
[Biovail, Wellbutrin, bupropion]
|
Sciele Pharma Signs Exclusive Zovirax(R) Promotional Agreement with Biovail
HSMN NewsFeed,
20 Dec 2006:
Biopharmaceuticals
[Sciele Pharma, Biovail, Zovirax, acyclovir]
|
Biovail Enters into Exclusive Promotional Agreement for Zovirax(R)
HSMN NewsFeed,
20 Dec 2006:
Biopharmaceuticals
[Biovail, Sciele Pharma, Zovirax, acyclovir]
|
IMPAX Announces FDA Approval of Generic Wellbutrin XL 300 mg
HSMN NewsFeed,
18 Dec 2006:
Biopharmaceuticals, Generics, FDA
[IMPAX Laboratories, Wellbutrin, Bupropion, Teva Pharmaceutical, GlaxoSmithKline]
|
Anchen Announces Approval of Generic Version of Wellbutrin XL(R)
HSMN NewsFeed,
15 Dec 2006:
Biopharmaceuticals, Generics, FDA
[Anchen Pharmaceuticals, Biovail, Wellbutrin XL, Bupropion]
|
Biovail Provides Strategy Update
HSMN NewsFeed,
6 Dec 2006:
Biopharmaceuticals, Drug Delivery, Distribution
[Biovail, Zovirax, Tiazac]
|
Endo Pharmaceuticals Appoints Charles Rowland as Chief Financial Officer
HSMN NewsFeed,
6 Dec 2006:
Biopharmaceuticals, Personnel
[Endo Pharmaceuticals]
|
Biovail Announces Senior Management Change
HSMN NewsFeed,
6 Dec 2006:
Biopharmaceuticals, Personnel
[Biovail]
|
Zogenix, Inc. Names Founding Management Team
HSMN NewsFeed,
28 Aug 2006:
Biopharmaceuticals, Drug Delivery, Personnel
[Zogenix]
|
Biovail and Athpharma Terminate Joint Development Agreement
HSMN NewsFeed,
24 Jul 2006:
Biopharmaceuticals
[Biovail, Athpharma, Bisochron, Isochron, Hepacol I, Hepacol II]
|
TriPath Imaging, Inc. Announces Promotions of Johnny D. Powers, Ph.D. to President, TriPath Oncology and James D. Petrilla to Senior Vice President, Commercial Operations
HSMN NewsFeed,
19 Jul 2006:
Diagnostics, Oncology, Personnel
[TriPath Imaging]
|
King Pharmaceuticals and Depomed Announce Agreement to Co-Promote Glumetza(TM)
HSMN NewsFeed,
28 Jun 2006:
Biopharmaceuticals, Endocrinology
[Depomed, King Pharmaceuticals, Glumetza, metformin, diabetes]
|
Biovail to Promote Novartis' Lescol(R) Franchise in Canada; Lescol(R) Provides Treatment Option for Patients Who Need a Statin to Reduce Cardiovascular Risk
HSMN NewsFeed,
19 May 2006:
Biopharmaceuticals
[Biovail Pharmaceuticals, Novartis]
|
Esprit Pharma Appoints Vice President of Trade
HSMN NewsFeed,
11 May 2006:
Biopharmaceuticals, Personnel
[Esprit Pharma, Glenn M. Esgro]
|
Biovail to Promote AstraZeneca's Zoladex(R) 3.6mg (Goserelin Acetate Implant) for Endometriosis in the United States and Puerto Rico
HSMN NewsFeed,
2 May 2006:
Biopharmaceuticals, Drug Delivery
[Biovail, AstraZeneca, Zoladex, goserelin, Endometriosis]
|
Biovail Names Gilbert Godin Senior Vice-President
HSMN NewsFeed,
27 Apr 2006:
Biopharmaceuticals, Personnel
[Biovail]
|
Biovail Launches Wellbutrin XL to Canadian Physicians
HSMN NewsFeed,
12 Apr 2006:
Biopharmaceuticals
[Biovail, Wellbutrin XL]
|
Schering-Plough Announces Gregory J. Szpunar Appointed Group Vice President, Global Project Management, Schering-Plough Research Institute
HSMN NewsFeed,
16 Mar 2006:
Biopharmaceuticals, Personnel
[Schering-Plough]
|
Biovail Announces Changes to Organizational Structure
HSMN NewsFeed,
7 Mar 2006:
Biopharmaceuticals
[Biovail, Biovail Drug Delivery, Biovail Pharmaceuticals]
|
Kos Reports Summary Results of Key Phase IV Research and Development Studies
HSMN NewsFeed,
23 Feb 2006:
Biopharmaceuticals
[Kos Pharmaceuticals, Niaspan, COMPELL Study]
|
Biovail Receives Approval for Wellbutrin(R) XL to Treat Depression in Canada
HSMN NewsFeed,
17 Jan 2006:
Biopharmaceuticals, Regulatory
[Biovail, Wellbutrin XL, bupropion]
|
|
|
Public
Feeds 
Full text >>